SCHEMBL18647201

SCHEMBL18647201

Fc1cc(Oc2ccccc2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.49
▸ PPARA Q07869 1/20 0.49
▸ LTA4H P09960 4/20 0.48
▸ TSHR P16473 1/20 0.48
▸ SLC6A4 P31645 4/20 0.46
▸ KMO O15229 1/20 0.45
▸ KCNH2 Q12809 3/20 0.44
▸ HTR2A P28223 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ MAOB P27338 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ SOS1 Q07889 1/20 0.44
▸ NR1H2 P55055 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17911539 0.85 SLC6A4 (0.49) PPARGPPARASLC6A4KMOKCNH2
SCHEMBL14662201 0.84 SOS1 (0.60) LTA4HTSHRSLC6A4KMOKCNH2
SCHEMBL21835261 0.82 MAOA (0.55) TSHRSLC6A4KCNH2HTR2AALDH1A1
SCHEMBL15385004 0.82 SLC6A4 (0.47) SLC6A4KCNH2HTR2AALDH1A1MAPT
SCHEMBL5537459 0.82 KMO (0.41) PPARGPPARASLC6A4KMOKCNH2
SCHEMBL10614755 0.81 KMO (0.62) LTA4HTSHRSLC6A4KMOKCNH2
SCHEMBL4336604 0.81 SOS1 (0.56) LTA4HTSHRSLC6A4HTR2AALDH1A1
SCHEMBL14753507 0.80 LTA4H (0.48) LTA4HTSHRALDH1A1MAPTKMT2A
Dimethylamine SCHEMBL27666829 0.79 SLC6A4 (0.58) SLC6A4KCNH2HTR2AALDH1A1MAPT
SCHEMBL14661923 0.78 POLB (0.50) PPARGPPARASLC6A4KCNH2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200247808-A1 Heterocyclic Tec-Family Kinase Inhibitors GB005, INC. 2020-08-06 — — US disclosed
WO-2017041180-A1 HETEROCYCLIC TEC-FAMILY KINASE INHIBITORS PHARMASCIENCE INC. (CA) 2017-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247808-A1 Heterocyclic Tec-Family Kinase Inhibitors TEC, BTK, LCK PPARG 4663/4885PPARA 4756/4885LTA4H 3608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback